Philadelphia Area Resources for COVID-19

Opioid Epidemic Response Training

The Health Federation of Philadelphia (HFP) provides training and technical assistance to address the range of knowledge and skills needed to identify, assess, and treat patients for opioid use disorder (OUD) in primary care settings. This includes advanced training on the evidence-based framework for providing medications for opioid use disorder in primary care, providing waiver training (federally required to prescribe buprenorphine for OUD) for primary care providers, and offering a range of supports for providers to increase their skills and improve treatment outcomes.

Philadelphia Department of Public Health (PDPH) enlisted HFP to offer live, interactive web-based waiver trainings and develop a follow up preceptorship program specifically designed to support integration of buprenorphine into primary care settings.  This Medication for Opioid Use Disorder (MOUD) Preceptorship program addresses the most common concerns and barriers cited by some newly waivered providers feeling hesitant to prescribe buprenorphine such as stigma, patient flow issues, time constraints, prior authorization challenges, worries about being inundated with patients with OUD and fears of patients misusing medication. 

In 2020, PDPH is offering an incentive program to encourage providers to complete their buprenorphine waiver training. For more information about this program, eligibility, and how to apply, please refer to the following FAQ or contact Catherine Abrams at or Caroline Drob at

Click for FAQ!

All programs will be online until further notice, and are free of charge, including continuing education credits. Please click on the following dates to register.

Online Buprenorphine Waiver trainings

8 Hour live Buprenorphine Waiver Training, March, 22, 2021 from 8:30 am - 5:30 pm

Online MOUD Preceptor Program

Part A: Integrating Medications for Opioid Use Disorder (MOUD) into Primary Care


Next date is Thursday, February 18, 2021

8:30 am – 4:30 pm


Requirements: Registrants must practice in Philadelphia and have already completed their waiver training, and must submit their license, resume, and waiver certificate prior to receiving their observation dates.

CE: CME has been applied for.

Faculty: Jeffrey Hom MD, MPH, Lara Carson Weinstein MD, MPH, DrPH, Serge-Emile Simpson, MD, Maggie Lowenstein, MD, MPhil, MSHP, Nicole O’Donnell, CRS, Clifford Brown, and Manik Chhabra, MD.

For more info and to register, click here.


Part B: “Clinical Experience”: Wednesday, January 27, 2021

3:00 pm – 5:00 pm ** Online

or scheduled individually on-site

CE: CME has been applied for

Registration is also open for the following MOUD preceptor dates:

Thursday, March 18, 2021

Thursday, April 8, 2021

Tuesday, May 11, 2021

About the MOUD Preceptor Program:

Our mini-residency training offers content that is not covered in the buprenorphine waiver training for primary care providers who are seeking to refine their skills.  Specific topics covered include diversion, continued substance use, benzodiazepine use, point of care testing, harm reduction and pain management.  Cases will be presented to help participants discuss ways to address patient needs and discussion is encouraged.  Our faculty is highly experienced and are eager to help others navigate buprenorphine prescribing.

Perinatal OUD Training:

Care and Treatment of Families Impacted by Opioid Use Disorder (OUD)

Friday, December 11, 2020

8:30 am – 12:00 pm


Requirements: Physicians, PAs, and NPs must have already completed their waiver training prior to this training.

Education of the entire obstetric care team is important so nurses and social workers are welcome to attend this program as essential members of the obstetric healthcare team.

CE: CME, CNE, and CE have been applied for

Faculty: Laura Hart, MD, Roschanak Mossabeb, MD, Emily Rosenthal, MD, and Deborah Hinds, MPH

About this program:

Obstetric providers in Philadelphia have witnessed the effects of the opioid crisis on patients and their families, including the high incidence of overdoses, many fatal, among postpartum women and the rising rates of neonatal abstinence syndrome in newborns.  In response, more OB providers are becoming X waivered and able to prescribe medication for opioid use disorder (MOUD) to their patients. 

The Health Federation of Philadelphia in collaboration with PDPH is offering a training to help support obstetric providers and nurses with details and reality-based explanations of best practices to treat and provide effective, compassionate care for pregnant and postpartum women with OUD. This training will supplement the content provided in the general waiver program, including buprenorphine dose titration and the experience of mothers following birth, to increase provider knowledge, comfort level, and experience when prescribing.  

For more info and to register, click here.